Artículo

γδ T-cell Receptors Derived from Breast Cancer–Infiltrating T Lymphocytes Mediate Antitumor Reactivity

Janssen, Anke ; Villacorta Hidalgo, Jose ; Beringer, Dennis X ; Van Dooremalen, Sanne ; Febilla, Fernando ; Van Diest, Eline ; Terrizzi, Antonela Romina Icon; Bronser, Peter ; Kock, Sylvia ; Schmitt-Gräff, Annette ; Werner, Martin ; Fisch, Paul ; Heise, Kerstin ; Follo, Marie ; Straetemans, Trudy ; Sebestyen, Zsolt ; Chudakov, Dmitry M ; Kasatskaya, Sofya A. ; Kuball, Jurgen ; Frenkel, Felix E. ; Ravens, Sarina ; Spierings, Eric ; Prinz, Immo ; Malkovsky, Miroslav ; Fisch, Paul ; Küppers, Ralf

Otros responsables

Fecha

04/2020

Editorial

American Association for Cancer Research

Revista

Cancer Immunology Research

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

2326-6066

eISSN

2326-6074

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

γδ T cells in human solid tumors remain poorly defined. Here, we describe molecular and functional analyses of T-cell receptors (TCRs) from tumor-infiltrating γδ T lymphocytes (γδ TILs) that were in direct contact with tumor cells in breast cancer lesions from archival material. We observed that the majority of γδ TILs harbored a proinflammatory phenotype and only a minority associated with the expression of IL17. We characterized TCRγ or TCRδ chains of γδ TILs and observed a higher proportion of Vδ2+ T cells compared to other tumor types. By reconstructing matched Vδ2- TCRγ and TCRδ pairs derived from single-cell sequencing, our data suggest that γδ TILs could be active against breast cancer and other tumor types. The reactivity pattern against tumor cells depended on both the TCRγ and TCRδ chains and was independent of additional co-stimulation through other innate immune receptors. We conclude that γδ TILs can mediate tumor reactivity through their individual γδ TCR pairs and that engineered T cells expressing TCRγ and δ chains derived from γδ TILs display potent antitumor reactivity against different cancer cell types and, thus, may be a valuable tool for engineering immune cells for adoptive cell therapies.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa